Landscapes / Targets

IGF-1R

6 drugs act on IGF-1R, in 14 active trials · Any stage · updated 19 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs6

DrugHow it worksCompanyStageNext dateDetails
Unmodified immunoglobulin
Approved Apr 2027Phase 4 trial completes
Monoclonal antibody
Amgen · Public AMGN
Approved —
—
Phase 3 Dec 2026Phase 3 trial completes
Tyrosine kinase inhibitor
Sling Therapeutics +1
Phase 3 30 Jun 2028Phase 3 trial completes
—
Phase 3 —
—
Phase 2 Jan 2027Phase 2 trial completes

About this list

Checked
6 of 6 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow IGF-1R

Following is part of Solo: you see every change to IGF-1R the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in